MedTrace Logo

The Therapeutic Use of Botulinum Toxin Type A in Subacute Cervical/Upper Back Pain

NCT00282958 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2015-03-05

No results posted yet for this study

Summary

To determine the therapeutic efficacy of Botox not only for chronic cervical/upper back pain but also for subacute pain.

Conditions

  • Subacute Cervical Pain
  • Subacute Upper Back Pain

Interventions

DRUG

Botulinum Toxin type a (Botox)

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • Palo Alto Veterans Institute for Research

    lead OTHER

Principal Investigators

  • Elaine Date, MD · VA Palo Alto Health Care System

  • Henry Lew, MD, Ph.D · VA Palo Alto Health Care System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-02-28
Completion
2006-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00282958 on ClinicalTrials.gov